MED13L syndrome
- Q87.85 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- ICD-10-CM Q87.85 is a new 2024 ICD-10-CM code that became effective on October 1, 2023.
- This is the American ICD-10-CM version of Q87.85 – other international versions of ICD-10 Q87.85 may differ.
Applicable To
- Asadollahi-Rauch syndrome
- Mediator complex subunit 13L syndrome
Code Also
- , if applicable, any associated manifestations such as:
- autism spectrum disorder (F84.0-)
- congenital malformations of cardiac septa (Q21-)
- epilepsy and recurrent seizures (G40.-)
- intellectual disability (F70-F79 )
The following code(s) above Q87.85 contain annotation back-references
that may be applicable to Q87.85:
- Q00-Q99 Congenital malformations, deformations and chromosomal abnormalities
- Q87 Other specified congenital malformation syndromes affecting multiple systems
- Q87.8 Other specified congenital malformation syndromes, not elsewhere classified
Present On Admission
- Q87.85 is considered exempt from POA reporting.
ICD-10-CM Q87.85 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 564 Other musculoskeletal system and connective tissue diagnoses with mcc
- 565 Other musculoskeletal system and connective tissue diagnoses with cc
- 566 Other musculoskeletal system and connective tissue diagnoses without cc/mcc
Code History
- 2024 (effective 10/1/2023): New code
Diagnosis Index entries containing back-references to Q87.85: